Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Balyasny Asset Management L.P.

Balyasny Asset Management L.P. decreased its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 41.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,689 shares of the company's stock after selling 2,624 shares during the quarter. Balyasny Asset Management L.P.'s holdings in Addus HomeCare were worth $462,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Dimensional Fund Advisors LP grew its stake in shares of Addus HomeCare by 1.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company's stock valued at $86,833,000 after buying an additional 10,434 shares during the last quarter. Capital Research Global Investors bought a new position in shares of Addus HomeCare in the fourth quarter worth about $51,149,000. TimesSquare Capital Management LLC increased its stake in Addus HomeCare by 28.5% in the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock worth $44,593,000 after buying an additional 78,835 shares during the period. Invesco Ltd. lifted its holdings in Addus HomeCare by 6.5% during the 4th quarter. Invesco Ltd. now owns 346,120 shares of the company's stock valued at $43,386,000 after buying an additional 21,266 shares in the last quarter. Finally, Northern Trust Corp boosted its position in Addus HomeCare by 3.3% in the 4th quarter. Northern Trust Corp now owns 285,872 shares of the company's stock valued at $35,834,000 after buying an additional 9,122 shares during the period. Institutional investors own 95.35% of the company's stock.

Addus HomeCare Price Performance

NASDAQ:ADUS traded down $1.40 during trading hours on Thursday, hitting $108.76. 7,353 shares of the company were exchanged, compared to its average volume of 165,748. The stock has a market capitalization of $2.00 billion, a price-to-earnings ratio of 24.89, a PEG ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a 52-week low of $88.96 and a 52-week high of $136.72. The company's 50 day moving average price is $101.50 and its 200-day moving average price is $113.53.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. The business had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business's revenue for the quarter was up 20.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.21 earnings per share. On average, equities analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on ADUS shares. Oppenheimer raised their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Stephens restated an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. Macquarie raised their target price on shares of Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. JMP Securities reissued a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Finally, StockNews.com lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. One analyst has rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, Addus HomeCare has a consensus rating of "Buy" and an average target price of $142.57.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.